Pay in 4 interest-free payments of $5.77 Learn more
Ships within 48 hours · Estimated delivery Aug 18 - Aug 23
Receptor timing behavior Selective agonist behavior Pathway coordination The blend combines a synthetic growth hormone secretagogue analog with a selective ghrelin receptor agonist to examine coordinated receptor activation
What It Targets Our Epithalon peptide is designed to target: Telomere attrition and genomic instability, key hallmarks of biological aging that correlate with agerelated disease risk. Agerelated decline in melatonin production and circadian rhythm amplitude that affects sleep quality, mood, and hormonal balance. Biomarkers and symptoms of aging such as reduced recovery, low resilience to stress, and tired but wired sleep patterns in midlife and beyond. Clients already focused on longevity who want to explore precision protocols that connect peptides, telomere testing, and lifestyle design
As humans age, their natural levels of GHK decline, going from around 200ng/mL in the plasma of a 20-year-old to 80ng/mL in a 60-year-old
The standard retatrutide dose schedule involves titration from 1 mg up to 8-12 mg over approximately 16 weeks, increasing every four weeks
Never use same needle and syringe twice, and dispose of all components as per local regulations
Clinical Update 11/09/2019 CoQ10 for Statin-Intolerance Many people experience muscle pain from taking cholesterol-lowering statin drugs
